Detailed price information for Tg Therapeutics (TGTX-Q) from The Globe and Mail including charting and trades.
TG Therapeutics, Inc. announced new data presentations for BRIUMVI® (ublituximab-xiiy) at the 2025 Consortium of Multiple Sclerosis Centers (CMSC) annual meeting, highlighting its efficacy for ...
ROCKVILLE, Md., April 28, 2025 /PRNewswire/ -- Kolon TissueGene participated in the 2025 Osteoarthritis Research Society International (OARSI) World Congress on Osteoarthritis, which took place in ...